A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ABT-199 in Female Patients With Systemic Lupus Erythematosus (SLE)

Study Identifier
M13-093
CT.gov Identifier
EudraCT Identifier
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Study Details

Medical Condition
  • Lupus (Systemic Lupus Erythematosus (SLE))
  • Study Drug
  • ABT-199
  • Phase
    Phase 1
    Sex
    Female
    Age
    18 - 65 Years

    Protocol Summary

    To assess the safety, tolerability and pharmacokinetics of ABT-199 in female subjects with Systemic Lupus Erythematosus.

    Study Locations

    Location
    Status
    Location
    Site Reference ID/Investigator# 89694
    Clearwater, Florida, United States, 33765
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 131720
    DeBary, Florida, United States, 32713
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 118637
    Miami, Florida, United States, 33136
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 124116
    Miami Lakes, Florida, United States, 33016
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 89693
    Orlando, Florida, United States, 32806
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 78256
    Overland Park, Kansas, United States, 66212
    Status
    Not applicable
    Showing {first} - {last} of {total} Results